Progress in novel NSCLC therapies in the UK
The management of patients with metastatic non-small cell lung cancer (NSCLC) is a field which has seen drastic improvement in the past few years. Here, Alastair Greystoke, PhD, of the University of N...
Author: VJOncology
Added: 06/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2018 Category: Cancer & Oncology Source Type: podcasts
Alunbrig - Drug for ALK-Positive Lung Cancer 56Overall Response Rate
Liviu Niculescu, MD PhD, Alunbrig - Drug for ALK-Positive Lung Cancer 56% Overall Response Rate at ASCO 2018
Author: Annual-Meeting
Added: 06/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 8, 2018 Category: Cancer & Oncology Source Type: podcasts
Alunbrig - Drug for ALK-Positive Lung Cancer 56% Overall Response Rate
Liviu Niculescu, MD PhD, Alunbrig - Drug for ALK-Positive Lung Cancer 56% Overall Response Rate at ASCO 2018
Author: Annual-Meeting
Added: 06/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 8, 2018 Category: Cancer & Oncology Source Type: podcasts
What Is a Mediastinoscopy_ [720p]
Dr. David Harpole, Duke University Medical Center, describes the mediastinoscopy and its use in lung cancer staging.
Author: cancergrace
Added: 05/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 24, 2018 Category: Cancer & Oncology Source Type: podcasts
My Top 5 ASCO 2018 Abstracts in Stage I-III NSCLC, Small Cell Lung Cancer, & amp; Mesothelioma (BMIC-037)
Dr. Jack West reviews his top 5 abstracts in stage I-III non-small cell lung cancer, small cell lung cancer, and mesothelioma at ASCO 2018, explaining why each is poised to change the landscape of pat...
Author: BeaconMedIC
Added: 05/23/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 23, 2018 Category: Cancer & Oncology Source Type: podcasts
Zoledronate or Denosumab for Lung Cancer with Bone Metastases [720p]
Dr. Benjamin Levy, Mount Sinai Health Systems, compares zoledronic acid and denosumab, two agents used for treatment of bone metastases in lung cancer.
Author: cancergrace
Added: 05/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 20, 2018 Category: Cancer & Oncology Source Type: podcasts
Hyperprogressive disease in lung cancer
Hyperprogressive disease is a new phenomenon observed in patients treated with anti-PD-1/PD-L1 immunotherapy, characterized by accelerated tumor growth. Interestingly, hyperprogressive disease can occ...
Author: VJHemOnc
Added: 05/17/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 17, 2018 Category: Cancer & Oncology Source Type: podcasts
Key findings of the ALEX study: Improved therapeutic options for ALK-positive NSCLC
The key findings of the anaplastic lymphoma kinase-positive non-small cell lung cancer (ALEX) study (NCT02075840) has established alectinib as a key treatment compared with crizotinib. In this talk, S...
Author: VJHemOnc
Added: 05/17/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 17, 2018 Category: Cancer & Oncology Source Type: podcasts
Lurbinectedin Focus - Small Cell Lung Cancer Virtual Roundtable
H. Jack West, MD, Medical Director, Thoracic Oncology Program, Swedish Cancer Institute, Founder & President, Grace Global Resource for Advancing Cancer Education leads this section on new data co...
Author: Cancer-Roundtables
Added: 05/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 15, 2018 Category: Cancer & Oncology Source Type: podcasts
Immunotherapy - Small Cell Lung Cancer Virtual Roundtable
H. Jack West, MD, Medical Director, Thoracic Oncology Program, Swedish Cancer Institute, Founder & President, Grace Global Resource for Advancing Cancer Education leads this section on immunothera...
Author: Cancer-Roundtables
Added: 05/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 15, 2018 Category: Cancer & Oncology Source Type: podcasts
Small Cell Lung Cancer Virtual Roundtable - ROVA-T
H. Jack West, MD, Medical Director, Thoracic Oncology Program, Swedish Cancer Institute, Founder & President, Grace Global Resource for Advancing Cancer Education leads this section on ROVA-T of a...
Author: Cancer-Roundtables
Added: 05/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 15, 2018 Category: Cancer & Oncology Source Type: podcasts
Small Cell Lung Cancer Virtual Roundtable
H. Jack West, MD, Medical Director, Thoracic Oncology Program, Swedish Cancer Institute, Founder & President, Grace Global Resource for Advancing Cancer Education leads a roundtable discussing newly r...
Author: Cancer-Roundtables
Added: 05/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 15, 2018 Category: Cancer & Oncology Source Type: podcasts
Lung Cancer Screening - Process and Potential Benefits [720p]
Dr. Jed Gorden, Swedish Cancer Institute, reviews the lung cancer screening process, including low-dose CT scanning, smoking cessation, follow-up testing and counseling, and describes the potential be...
Author: cancergrace
Added: 05/12/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 12, 2018 Category: Cancer & Oncology Source Type: podcasts
Immunotherapy as First-Line Treatment [720p]
Dr. Jack West, Swedish Cancer Institute, raises the question of whether to use immune checkpoint inhibitors as first-line treatment of lung cancer, alone or in combination with chemotherapy.
Author: cancergrace
Added: 05/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 12, 2018 Category: Cancer & Oncology Source Type: podcasts
Immunotherapy Combinations [720p]
Dr. Jack West, Swedish Cancer Institute, discusses current trials seeking to determine the efficacy of combining immunotherapy agents in lung cancer
Author: cancergrace
Added: 05/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 12, 2018 Category: Cancer & Oncology Source Type: podcasts
